Sales for the quarter increased 7.7 percent. Organic sales increased 1.6 percent, acquisitions increased sales 2.3 percent and foreign currency translation increased sales 3.8 percent.Diluted EPS ...

Diluted earnings per share ('EPS”) of $2.36Invested $96 million in water and wastewater utility infrastructure during 2025, successfully delivering the planned 2025 capital investmentsUtility ...

Adjusted EBITDA for Q4 was $156 million, up 11%, with margin expanding to 7.6%. Adjusted diluted earnings per share were $2.96, up 11%. For the full year, adjusted diluted earnings per share were ...

CEO Daniel Fisher opened by highlighting that beverage can volumes grew 4.2%, comparable operating earnings increased 5.1%, and comparable diluted earnings per share rose 12.1%. Fisher emphasized, "we ...

The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and ...

Information reconciling certain forward-looking GAAP measures to non-GAAP measures related to FY 2025 guidance, including organic net sales growth, adjusted operating margin and adjusted free cash ...

CVS Health reported past fourth-quarter 2025 sales of US$34,017 million and revenue of US$105,693 million, with quarterly net income rising to US$2,943 million and diluted EPS from continuing ...